Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

4.86
Delayed Data
As of Feb 05
 -0.19 / -3.76%
Today’s Change
4.15
Today|||52-Week Range
20.43
-37.21%
Year-to-Date

Today’s Trading

Previous close5.05
Today’s open5.07
Day’s range4.79 - 5.16
Volume92,289
Average volume (3 months)114,027
Market cap$75.1M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+10.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DPRXDipexium Pharmaceuti...+0.32+4.57%
STMLStemline Therapeutic...-0.12-2.72%
TTNPTitan Pharmaceutical...+0.06+1.59%
EPRSEPIRUS Biopharmaceut...+0.02+0.63%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$15.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers